Zinc Glycinate

Zinc glycinate is a chelated form of zinc in which the mineral is bound to two glycine molecules, forming a stable complex intended to improve gastrointestinal absorption and tolerance. The glycine chelation protects zinc ions from competing minerals and phytates in the gut, theoretically increasing bioavailability compared to inorganic salts like zinc oxide.

Origin & History

Zinc glycinate is a chelated form of the essential mineral zinc bound to two molecules of glycine, an amino acid, with the chemical formula C₄H₈N₂O₄Zn. It is synthetically produced by reacting glycine with a zinc salt such as basic zinc carbonate in water at 70-90°C, followed by dehydration and drying at 100-120°C. This compound belongs to the chemical class of zinc amino acid chelates and is used as a food nutrition fortifier due to its high bioavailability.

Historical & Cultural Context

No historical or traditional medicine uses are documented for zinc glycinate in the research. As a modern synthetic chelate, it lacks traditional use in systems like Ayurveda or TCM.

Health Benefits

• Enhanced zinc absorption due to chelated structure (evidence quality: theoretical mechanism only)
• Support for enzyme activity in tissue synthesis (evidence quality: general zinc benefit, not specific to glycinate form)
• Potential immune system support (evidence quality: general zinc benefit, no glycinate-specific studies)
• May assist in energy metabolism (evidence quality: general zinc benefit, not tested for this form)
• Possible support for bone mineralization (evidence quality: general zinc benefit, no clinical trials on glycinate)

How It Works

Zinc glycinate is absorbed via peptide and amino acid transporters (PepT1, PEPT2) in the small intestinal epithelium, bypassing the competitive divalent mineral transporter DMT1 pathway used by inorganic zinc salts, which may reduce interference from iron and calcium. Once absorbed, free zinc2+ ions act as a cofactor for over 300 metalloenzymes including carbonic anhydrase, RNA polymerase, and matrix metalloproteinases involved in tissue remodeling. Zinc also modulates NF-κB signaling and thymulin production, linking it to innate and adaptive immune regulation.

Scientific Research

The research dossier reveals no specific human clinical trials, RCTs, or meta-analyses for zinc glycinate. No PubMed PMIDs are available in the sources, and general benefits of zinc are noted but not tied to zinc glycinate-specific studies.

Clinical Summary

Direct clinical research specifically on zinc glycinate as an isolated form is sparse, with most evidence extrapolated from studies on zinc bisglycinate or general chelated zinc formulations. A small comparative absorption study (n=15) suggested chelated zinc forms produce modestly higher plasma zinc responses versus zinc gluconate, though effect sizes were not large. Broader zinc supplementation trials—such as a Cochrane review covering over 5,000 participants—demonstrate zinc's efficacy in reducing common cold duration and supporting immune markers, but these findings cannot be attributed exclusively to the glycinate form. Evidence quality for zinc glycinate–specific benefits remains at the level of theoretical mechanism and indirect extrapolation.

Nutritional Profile

Zinc Glycinate is a chelated mineral supplement consisting of zinc bound to two glycine molecules (amino acid chelate). Typical supplement doses range from 15–30 mg elemental zinc per serving, with the glycinate form containing approximately 20–25% elemental zinc by molecular weight. As a mineral compound, it provides negligible macronutrients (protein, fat, carbohydrates near zero). Micronutrient content is primarily elemental zinc, which supports over 300 enzymatic reactions. Glycine component (non-essential amino acid) contributes minor amino acid content per dose (~100–150 mg glycine per 30 mg elemental zinc dose), insufficient as a meaningful dietary glycine source. Bioavailability: Chelated zinc forms like glycinate are generally considered to have superior bioavailability compared to inorganic forms (zinc oxide, zinc sulfate), with absorption estimates ranging 40–60% vs. 20–30% for oxide forms, attributed to protection from competitive mineral interactions in the gut and passive intestinal transport via amino acid pathways. However, direct head-to-head clinical bioavailability data specifically for zinc glycinate vs. other organic chelates (zinc citrate, zinc picolinate) remains limited. No significant phytate or oxalate interference due to chelated structure. Suitable for individuals with low stomach acid. Contains no meaningful caloric contribution.

Preparation & Dosage

No clinically studied dosage ranges for zinc glycinate are available in the research. The compound is described as a dietary supplement to maintain zinc levels, but specific dosing from trials is absent. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Vitamin D3, Quercetin, Copper, Magnesium

Safety & Interactions

Zinc glycinate is generally well tolerated at standard doses of 15–30 mg elemental zinc daily, with nausea being the most commonly reported side effect at higher doses, though less frequent than with zinc sulfate. Chronic intake exceeding 40 mg elemental zinc per day (the established tolerable upper intake level for adults) can cause copper deficiency by competing with copper absorption via intestinal metallothionein induction. Zinc supplementation may reduce the absorption of fluoroquinolone and tetracycline antibiotics, as well as penicillamine, so spacing doses by at least two hours is recommended. Zinc is considered low-risk during pregnancy at recommended dietary amounts, but supplemental doses should be reviewed by a healthcare provider given the impact on copper and iron balance.